IFx-Hu2.0 vaccine

IFx-Hu2.0 · TuHURA Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IFx-Hu2.0 vaccine, covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers [Phase 1]